Whole-Exome Sequencing Identifies Novel Recurrent Somatic Mutations in Sporadic Parathyroid Adenomas

作者：Wei, Zhe; Sun, Bin; Wang, Zong-ping; He, Jin-wei; Fu, Wen-zhen; Fan, You-ben^*; Zhang, Zhen-lin^*

来源：Endocrinology, 2018, 159(8): 3061-3068.

DOI：10.1210/en.2018-00246

• METHYLTRANSFERASE GENE EZH2
• PRIMARY HYPERPARATHYROIDISM
• MYELODYSPLASTIC SYNDROMES
• CYCLIN D1
• TUMORS
• HRPT2
• PARAFIBROMIN
• EXPRESSION
• CARCINOMA
• POPULATION

Primary hyperparathyroidism is commonly caused by excess production of parathyroid hormone from sporadic parathyroid adenomas. However, the genetic architecture of sporadic primary hyperparathyroidism remains largely uncharacterized, especially in the Chinese population. To identify genetic abnormalities that may be involved in the etiology of sporadic parathyroid adenomas and to determine the mutation frequency of previously identified genes in the Chinese population, we performed whole-exome sequencing of 22 blood-tumor pairs from sporadic parathyroid adenomas. The most important finding is the recurrently mutated gene, ASXL3, which has never been reported in parathyroid tumors before. Moreover, we identified two different somatic mutations in the CDC73 gene and one somatic mutation in the EZH2 gene. The Y54X mutation in the CDC73 gene was previously identified in parathyroid carcinomas, which proved that parathyroid adenomas and carcinomas might possess similar molecular signatures. No mutations in the MEN1 or CCND1 genes were observed in our study. Thus, our data provide insights into the genetic pathogenesis of sporadic parathyroid adenomas and are valuable for the development of diagnostic and therapeutic approaches for sporadic primary hyperparathyroidism.

• 出版日期2018-8
• 单位上海交通大学